New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid
Go back to New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid| Immune Pharmaceuticals Inc. NEW (NASDAQ: IMNP) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $1.10 | |||
| Open | $36.15 | 52 Week Low | $0.16 | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.06 | EPS | $0.00 | |||
| Volume | 0 | |||||
